Henrietta Lacks

Medical exploitation of Black people in America goes far beyond the cells stolen from Henrietta Lacks that produced modern day miracles

Retrieved on: 
Martedì, Agosto 8, 2023

During her treatment, a sample of her cancer cells was taken without her knowledge or consent.

Key Points: 
  • During her treatment, a sample of her cancer cells was taken without her knowledge or consent.
  • Henrietta Lacks’ cells, known as HeLa cells, have had a profound impact on medical science since they were first taken from Lacks in 1951.
  • Lacks is one of the most well-known examples of medical exploitation on a Black body.

Medical abuse is a part of Black history

    • Medical exploitation and intentional abuse of members of the Black community is an often overlooked part of Black history.
    • The Tuskegee experiment is one of the most well-known examples of medical exploitation in the Black community.
    • But as revealed in medical ethicist Harriet A. Washington’s groundbreaking book “Medical Apartheid,” the medical exploitation of the Black community extended far beyond Tuskegee.

Grave robbing in Black communities

    • In turn, more cadavers were needed, but the demand for cadavers far exceeded the supply.
    • The solution at the time was grave robbing.
    • At the turn of the 18th century, most of New York City’s dissection tables were full of Black bodies, despite members of the Black community’s accounting for only 15% of the population at the time.

Unethical experiments on the incarcerated

    • From the 1950s through the 1970s, Philadelphia health officials allowed the prominent researcher Dr. Albert M. Kligman to conduct dangerous experiments on incarcerated people, most of whom were Black.
    • Kligman repeatedly and purposely exposed Black men to dermatological, biochemical and pharmaceutical experiments.
    • The city of Philadelphia and related institutions officially apologized in October 2022, but the apology does not remedy the lifelong scars and lingering health impacts from the experiments.
    • Incarcerated individuals in Arkansas were given a cocktail of drugs, including Ivermectin, to treat COVID-19.

Why it matters

    • It is also important to show how racism is still prevalent in contemporary medicine and public health.
    • The study further found that nearly half of the medical students in the study believed Black people have less sensitive nerve endings.
    • It’s my belief that revealing the dark history of medical racism is key to making sure that past injustices do not recur.

Attorney Benjamin L. Crump to Keynote 123rd National Black Business Conference

Retrieved on: 
Martedì, Agosto 8, 2023

WASHINGTON, Aug. 8, 2023 /PRNewswire/ -- The 123rd National Black Business Conference presented by Comerica Bank is thrilled to announce Attorney Benjamin L. Crump as the keynote speaker. This momentous event, presented by Comerica Bank, will take place from August 23-27, 2023, at the Hyatt Regency Atlanta Hotel in Atlanta, GA.

Key Points: 
  • Black America's Attorney General to Engage the Nation's Black Business Community in Atlanta, GA
    WASHINGTON, Aug. 8, 2023 /PRNewswire/ -- The 123rd National Black Business Conference presented by Comerica Bank is thrilled to announce Attorney Benjamin L. Crump as the keynote speaker.
  • The conference has a rich history dating back to its origins with the National Business League, formerly known as the National Negro Business League, founded by the legendary Booker T. Washington.
  • Inaugurated in Boston, Massachusetts, on August 23, 1900, the event has evolved into a collaborative effort with the newly formed National Alliance for Black Business (2022), partnering with institutions like the National Business League (1900), National Black Chamber of Commerce (1993), and the World Conference of Mayors (1986).
  • The Atlanta Business League and the Greater Georgia Black Chamber of Commerce shall serve as the hosts for this year's conference.

Settlement with family of Henrietta Lacks is an opportunity to reflect on inequalities in genetic research

Retrieved on: 
Venerdì, Agosto 4, 2023

It was also the day the Lacks family reached a settlement with Thermo Fisher Scientific, the biotech company that used and profited from her “HeLa” cells.

Key Points: 
  • It was also the day the Lacks family reached a settlement with Thermo Fisher Scientific, the biotech company that used and profited from her “HeLa” cells.
  • Though the details remain confidential, this settlement is a long-awaited moment of justice and victory for Lacks and her family.
  • However, the inequalities suffered by Lacks remain problems of the present.

Henrietta Lacks’s story

    • Her cells were taken and retained for research purposes by white physicians and researchers at the hospital.
    • It was Rebecca Skloot’s 2010 book The Immortal Life of Henrietta Lacks that drew attention to Lacks’s story and highlighted the racialized and patriarchal nature of medical ethics and research practices.
    • Advocates — mainly people of colour — used the pandemic and subsequent COVID-19 vaccine developments to bring Lacks’s story back to life.

Not just her: Other stories of inequality

    • Moore had hairy cell leukemia and, as part of his treatment, underwent a splenectomy at the University of California Los Angeles Medical Centre in 1976.
    • Like Lacks’s, Moore’s cells had been unknowingly and unlawfully processed and patented as the “Mo” cell line.
    • This violated the Havasupai’s consent agreement and had deeper repercussions, as these topics were considered taboo by the tribe.

The fight isn’t over yet

    • But it should also serve as a reminder that the fight for a fairer and more equitable framework of medical ethics and genetic research is not over.
    • Genetic materials are generally treated like any other objects and little to no consideration is given to the person.

Health equity at heart of Texas Biomed's 3rd Global Health Symposium

Retrieved on: 
Lunedì, Aprile 24, 2023

SAN ANTONIO, April 24, 2023 /PRNewswire/ -- Texas Biomedical Research Institute's 3rd Global Health Symposium on May 18 and 19 will convene experts from across the nation and the world to discuss how community, trust and science can help build health equity.

Key Points: 
  • SAN ANTONIO, April 24, 2023 /PRNewswire/ -- Texas Biomedical Research Institute's 3rd Global Health Symposium on May 18 and 19 will convene experts from across the nation and the world to discuss how community, trust and science can help build health equity.
  • More than 60 global health executives, healthcare providers, philanthropists, business leaders, scientists, educators and students will be featured during 12 panel sessions and three keynote addresses.
  • "But to truly achieve that, we must bring together innovators from across many different sectors and global communities to collaborate and build health equity."
  • Decolonizing Global Health: What should be the target of this movement and where does it lead us?

Jumo Health Launches Suite of Services to Drive Health Equity in Clinical Trials

Retrieved on: 
Mercoledì, Marzo 1, 2023

NEW HAVEN, Conn. and LOS ANGELES, March 1, 2023 /PRNewswire/ -- Jumo Health, the global provider of age appropriate, culturally sensitive medical education, announced today that, together with the I Choose Life Foundation (ICLF), it has expanded its health equity service line to include the recruitment and retention of people of color in clinical trials.

Key Points: 
  • This group of a half million people offers rare access to a community that is historically underrepresented in clinical trials.
  • While approximately 14% of the United States population is Black, the community only makes up approximately 5% of clinical trial participants.
  • "Jumo Health explains difficult medical concepts in ways people can understand and act upon," stated Kevin Aniskovich, President and CEO of Jumo Health.
  • Oliver Buie - Warren Chapel, Los Angeles, CA
    Working together, Jumo Health, ICLF, and the CARES Council seek to ensure that Black participants are appropriately represented in future clinical trials.

The American Kratom Association Strongly Endorses Dr. Jack Henningfield's Review That Questions The Conclusions Related To Kratom Safety In The Eggleston Et Al. Brief Report On "Kratom Use And Toxicities In The United States"

Retrieved on: 
Martedì, Luglio 16, 2019

Jack Henningfield, Ph.D., Vice President, Research, Health Policy, and Abuse Liability, PinneyAssociates, and Professor, Behavioral Biology, Adjunct, The Johns Hopkins University School of Medicine, stated, "The brief report by Eggleston et al.

Key Points: 
  • Jack Henningfield, Ph.D., Vice President, Research, Health Policy, and Abuse Liability, PinneyAssociates, and Professor, Behavioral Biology, Adjunct, The Johns Hopkins University School of Medicine, stated, "The brief report by Eggleston et al.
  • lacks the scientific rigor to support its conclusions about kratom use and safety and to meaningfully address the potential risk of kratom products for the public.
  • The attached report from Dr. Henningfield outlines the inaccuracies and flawed assumptions that were used by Dr. Eggleston and his fellow contributors to his Brief Report.
  • Regulation, including standards for kratom product contents and labeling, and further research is needed on kratom use, effects and safety," wrote Dr. Henningfield.